HomeKeren SookneHomeCSL Behring Uses Specialty Label System to Blind Vials for Clinical TrialsThere are visible differences between the candidate and the placebo in this international Phase III trial. The blinding system combines a cap system that completely covers the vial with a booklet label for multilingual product information.HomeLive from PDA/FDA: FDA Considers Incentivizing Quality Management Maturity (QMM)The Agency is soliciting feedback from manufacturers on assessing and rewarding QMM through Oct. 2020. Reduced audit frequency may one day be an incentive for high performers.HomePoseidon: Call to Participate in Pre-Commercial Ocean Freight TrialsCOVID-19 immunization will need a staggering collaborative effort in intercontinental transportation. Pharmaceutical manufacturers are invited to register their interest in participating in the final Poseidon trials.HomeVariable Barcodes to Boost COVID-19 Test Kit ExperienceScannable point of care tests were designed to increase test accuracy, collect data, and take the guesswork out of reading results.
![“Another key [UDI] benefit, because we're calling that product by the same name across the healthcare supply chain… rich and robust data that we can access around supply consumption and utilization rates. One of the buzz terms we've heard during the COVID-19 crisis was what's my burn rate? How fast am I going through gowns, masks, gloves?” – Mike Schiller, Senior Director at AHRMM](https://img.automationworld.com/files/base/pmmi/all/image/2020/08/UDI.5f4d326e41d53.png?auto=format&fit=crop&h=146&w=340)
